Lovell A. Jones, PhD, Oral History Interview, January 15, 2014
Major Topics Covered:
- Personal and educational background; Evolution of awareness of minority issues and health disparity
- Evolution of research on the natural/synthetic estrogens and gynecologic cancers
- Development of combination therapies for ovarian cancer
- Overview of health inequity (health disparity) and minority health needs in the context of American culture, Texas, Houston, and MD Anderson
- Diversity at MD Anderson; climate for minorities; attitudes of leadership
Chapter 01: An Interest in Estrogen and an Important Discovery
Chapter 02: A Conversation with Dr. R. Lee Clark
Chapter 03: Coming to MD Anderson to Link Discovery to Delivery of Care
Chapter 04: The First African-American Basic Researcher at MD Anderson
Chapter 05: The Minority Faculty Association; What Health Disparities Can Mean
The Historical Resources Center, Research Medical Library, The University of Texas Cancer Center
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center, University of Texas System. M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute at Houston, University of Texas M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute
History of Science, Technology, and Medicine | Oncology | Oral History
Jones, Lovell A. PhD and Rosolowski, Tacey A. PhD, "Lovell A. Jones, PhD, Oral History Interview, January 15, 2014" (2014). Interview Sessions. 98.
Conditions Governing Access
About the Interview
About the Interview Subject:
Dr. Lovell Jones (b. 12 January 1949, Baton Rouge, Louisiana) came to MD Anderson in 1980 to join the faculty of the Department of Gynecologic Oncology and Reproductive Medicine. He retired in 2013 and holds the title of Professor Emeritus in the Department of Health Disparities Research in the Division of Cancer Prevention and Population Sciences. Dr. Jones established his research reputation through his work on the role of synthetic estrogens in gynecologic cancers. Later he focused on health disparities research. He worked at MD Anderson and on the national stage to develop the understanding of “health equity.” He was responsible for developing minority health initiatives such as the Biennial Symposium Series on ‘Minorities, the Medically Underserved and Cancer’ (’88), the National Black Leadership Initiative on Cancer (’95), the Inter-cultural Cancer Council, and the Health Disparities Education Awareness Research and Training Consortium ’02).